A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-09-28
DOI
10.1038/s41398-022-02192-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Systematic Review of Circulatory microRNAs in Major Depressive Disorder: Potential Biomarkers for Disease Prognosis
- (2022) Madiha Rasheed et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine
- (2022) Li Ma et al. Translational Psychiatry
- Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers
- (2022) Ellen Scotton et al. BIOCHEMICAL PHARMACOLOGY
- Validity of chronic restraint stress for modeling anhedonic-like behavior in rodents: a systematic review and meta-analysis
- (2022) Ye Mao et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Ketamine: anesthetic, psychotomimetic, antidepressant, or anthelmintic?
- (2022) Kenji Hashimoto MOLECULAR PSYCHIATRY
- Suppression of abnormal α-synuclein expression by activation of BDNF transcription ameliorates Parkinson’s disease-like pathology
- (2022) Qianqian Cao et al. Molecular Therapy-Nucleic Acids
- Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity
- (2022) Qianqian Cao et al. Cell Death Discovery
- Blood miR-144-3p: a novel diagnostic and therapeutic tool for depression
- (2022) Yentl Y. van der Zee et al. MOLECULAR PSYCHIATRY
- The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine
- (2022) Li Ma et al. NEURON
- A bibliometric analysis of research on (R)-ketamine from 2002 to 2021
- (2022) Teng He et al. NEUROPHARMACOLOGY
- Arketamine, a new rapid-acting antidepressant: A historical review and future directions
- (2022) Ji-chun Zhang et al. NEUROPHARMACOLOGY
- A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
- (2021) Adriana Feder et al. AMERICAN JOURNAL OF PSYCHIATRY
- Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents
- (2021) Wei Yao et al. Translational Psychiatry
- Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response
- (2021) Lisha Zhou et al. JOURNAL OF AFFECTIVE DISORDERS
- Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
- (2021) Yan Wei et al. MOLECULAR PSYCHIATRY
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
- (2021) Jordi Bonaventura et al. MOLECULAR PSYCHIATRY
- miR-98-5p plays a critical role in depression and antidepressant effect of ketamine
- (2021) Chaoli Huang et al. Translational Psychiatry
- The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice
- (2021) Anna Rafało-Ulińska et al. BEHAVIOURAL BRAIN RESEARCH
- (R)-Ketamine ameliorates lethal inflammatory responses and multi-organ injury in mice induced by cecum ligation and puncture
- (2021) Jiancheng Zhang et al. LIFE SCIENCES
- Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
- (2021) Wei Yao et al. MOLECULAR PSYCHIATRY
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- A historical review of antidepressant effects of ketamine and its enantiomers
- (2020) Yan Wei et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
- (2020) Kai Zhang et al. Translational Psychiatry
- Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?
- (2020) Kenji Hashimoto PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
- (2020) Kenji Hashimoto BIOCHEMICAL PHARMACOLOGY
- miR-132-5p regulates apoptosis and autophagy in MPTP model of Parkinson’s disease by targeting ULK1
- (2020) Jianli Zhao et al. NEUROREPORT
- Assessment of Ketamine and its Enantiomers in an Organophosphate-Based Rat Model for Features of Gulf War Illness
- (2020) Jackie Zhu et al. International Journal of Environmental Research and Public Health
- Prophylactic use of ketamine reduces postpartum depression in Chinese women undergoing cesarean section
- (2019) Jia-Hui Ma et al. PSYCHIATRY RESEARCH
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
- (2019) Jennifer L. Phillips et al. AMERICAN JOURNAL OF PSYCHIATRY
- Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
- (2019) Lijia Chang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Prophylactic (R,S)-ketamine selectively protects against inflammatory stressors
- (2019) Alessia Mastrodonato et al. BEHAVIOURAL BRAIN RESEARCH
- MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior
- (2019) Lauren Allen et al. MOLECULAR PSYCHIATRY
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
- (2019) Chun Yang et al. Translational Psychiatry
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ventral CA3 Activation Mediates Prophylactic Ketamine Efficacy Against Stress-Induced Depressive-like Behavior
- (2018) Alessia Mastrodonato et al. BIOLOGICAL PSYCHIATRY
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression
- (2018) Yuan Fang et al. JOURNAL OF AFFECTIVE DISORDERS
- Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of ( R,S )-ketamine and ( S )-ketamine, but not ( R )-ketamine
- (2018) Zheng Tian et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Regulation of microRNA function in animals
- (2018) Luca F. R. Gebert et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- An update on ketamine and its two enantiomers as rapid-acting antidepressants
- (2018) Kai Zhang et al. Expert Review of Neurotherapeutics
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
- (2017) Yukihiko Shirayama et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
- (2017) Chun Yang et al. Translational Psychiatry
- Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
- (2016) Rebecca A. Brachman et al. BIOLOGICAL PSYCHIATRY
- Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
- (2016) Yukihiko Shirayama et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
- (2016) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
- (2016) Chun Yang et al. PSYCHIATRY RESEARCH
- Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
- (2015) J. W. Murrough et al. PSYCHOLOGICAL MEDICINE
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Integrating the roles of long and small non-coding RNA in brain function and disease
- (2014) G Barry MOLECULAR PSYCHIATRY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started